Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MO › Rolla › NPI 1891766051
Hospital

Phelps County Regional Medical Center

Phelps County Regional Medical Center was paid $38.36M by Medicaid between Jan 2018 and Dec 2024, across 184 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 12% of everything it billed.

33Billing provider infoPHELPS COUNTY REGIONAL MEDICAL CENTER
ROLLA, MO 65401
33aNPI1891766051assigned 01/27/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$38.36M
24GClaims375,939
24DCodes billed184
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Missouri

Rank by total paid#8 of 74
Median peer was paid$4.44M
This provider vs. median8.6×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500K$1.0M$1.5M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201837,069$10.24M
201932,936$6.91M
202030,127$3.64M
202140,493$1.57M
202245,281$3.03M
202399,449$6.78M
2024incomplete90,584$6.19M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
G0463 Hospital outpatient clinic visit for assessment and management of a patient 12% 57,016 51,966 $4.76M
X4011 State-specific procedure code 10% 13,611 12,918 $3.97M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 9.4% 14,929 13,581 $3.59M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 7.7% 16,260 14,269 $2.94M
Y7506 7.6% 18,599 16,094 $2.91M
85025 Blood count; complete (CBC), automated, and automated differential WBC count 6.7% 37,030 33,531 $2.58M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 6.5% 13,714 12,589 $2.49M
80053 Comprehensive metabolic panel 6.2% 38,266 34,790 $2.39M
X4006 4.7% 1,789 1,483 $1.80M
81001 3.5% 17,572 16,634 $1.34M
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 2.7% 13,262 12,194 $1.03M
Y7507 2.3% 2,491 2,209 $872K
172 more codes
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.5% 5,536 $565K
87400 1.2% 1,281 $464K
71045 Radiologic examination, chest; single view 1.1% 6,556 $433K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 1.1% 6,052 $407K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 2,867 $371K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 11,317 $353K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 1,925 $295K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 1,812 $286K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 1,277 $269K
84484 <1% 5,490 $232K
83690 <1% 8,237 $222K
87070 <1% 716 $220K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 3,318 $201K
X4003 <1% 1,670 $164K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 1,365 $162K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 1,693 $144K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 457 $136K
96361 Intravenous infusion, hydration; each additional hour <1% 3,586 $110K
81025 <1% 3,913 $103K
87086 Culture, bacterial; quantitative colony count, urine <1% 2,514 $100K
95165 Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials <1% 328 $98K
83880 <1% 3,036 $97K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 731 $94K
20610 <1% 669 $86K
70450 Computed tomography, head or brain; without contrast material <1% 1,047 $81K
29580 <1% 1,221 $79K
96375 Therapeutic injection; each additional sequential IV push <1% 2,752 $78K
G0378 Hospital observation service, per hour <1% 251 $77K
42820 Tonsillectomy and adenoidectomy; younger than age 12 <1% 25 $77K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 3,511 $76K
84443 Thyroid stimulating hormone (TSH) <1% 2,581 $72K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 515 $70K
88342 <1% 464 $64K
95117 <1% 1,658 $60K
95115 <1% 1,642 $56K
A0425 Ground mileage, per statute mile <1% 2,053 $55K
64493 <1% 137 $54K
87807 <1% 360 $48K
77386 <1% 113 $47K
A0427 Emergency ambulance ride, advanced life support <1% 671 $43K
D7999 <1% 12 $39K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 945 $38K
88313 <1% 90 $36K
87040 <1% 151 $35K
87634 <1% 775 $33K
73560 <1% 394 $32K
85610 <1% 500 $32K
64490 <1% 224 $31K
80048 Basic metabolic panel (calcium, ionized) <1% 917 $31K
20611 <1% 238 $30K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 43 $28K
83036 Hemoglobin; glycosylated (A1C) <1% 1,551 $24K
82150 <1% 136 $24K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 218 $23K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 429 $23K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 43 $22K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 955 $22K
71046 Radiologic examination, chest; 2 views <1% 311 $21K
85730 <1% 434 $20K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 204 $20K
93017 <1% 169 $18K
36415 Collection of venous blood by venipuncture <1% 1,645 $18K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 103 $17K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 38 $17K
90834 Psychotherapy session, about 45 minutes <1% 239 $16K
95811 <1% 30 $16K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 538 $16K
80061 Lipid panel <1% 1,117 $15K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 130 $15K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 41 $15K
99152 <1% 474 $14K
64483 <1% 71 $14K
77336 <1% 159 $14K
J3490 Unclassified drugs <1% 1,674 $14K
83605 <1% 884 $12K
99214 Doctor's office visit, returning patient (more involved) <1% 229 $12K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 156 $12K
64494 <1% 52 $11K
73630 <1% 221 $11K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 7,275 $11K
95911 <1% 30 $10K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 80 $9K
83735 <1% 1,443 $8K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 346 $8K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 12 $8K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 327 $8K
80081 <1% 131 $7K
90837 Psychotherapy session, about an hour <1% 90 $7K
J2704 Injection, propofol, 10 mg <1% 503 $6K
99213 Doctor's office visit, returning patient (routine) <1% 183 $6K
G0260 Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography <1% 20 $6K
77300 <1% 26 $6K
88341 <1% 122 $6K
77334 <1% 18 $5K
51798 <1% 194 $5K
86850 <1% 13 $5K
88142 <1% 294 $4K
36591 <1% 324 $4K
76801 <1% 13 $4K
85027 <1% 1,344 $4K
A0429 Emergency ambulance ride, basic life support <1% 77 $4K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 155 $4K
85379 <1% 24 $3K
87081 <1% 92 $3K
86803 <1% 285 $3K
11056 <1% 103 $3K
64491 <1% 148 $3K
0001A <1% 163 $2K
27096 <1% 48 $2K
0002A <1% 127 $2K
82950 <1% 295 $2K
73562 <1% 39 $2K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 39 $2K
94060 <1% 15 $2K
92523 <1% 12 $2K
92567 <1% 73 $2K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed <1% 14 $2K
97602 <1% 57 $2K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,011 $1K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 507 $1K
73030 <1% 43 $1K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 221 $1K
69210 <1% 52 $1K
83970 <1% 49 $1K
84439 <1% 134 $1K
73564 <1% 14 $988.48
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 71 $956.03
86780 <1% 87 $946.33
97161 <1% 49 $943.61
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 57 $924.45
11721 <1% 135 $911.55
81002 <1% 318 $889.12
80069 <1% 171 $855.62
82728 <1% 87 $850.29
J0690 Injection, cefazolin sodium, 500 mg <1% 24 $822.60
72170 <1% 14 $743.88
87186 <1% 98 $598.37
84481 <1% 27 $582.51
83550 <1% 88 $558.41
J3010 Injection, fentanyl citrate, 0.1 mg <1% 431 $502.90
0012A <1% 49 $469.80
83655 <1% 26 $456.74
83540 <1% 88 $412.79
87088 <1% 67 $314.85
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 90 $302.14
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 12 $288.97
87077 <1% 61 $251.09
82747 <1% 15 $248.69
84702 <1% 15 $216.15
86140 <1% 62 $192.93
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 16 $171.04
84460 <1% 50 $138.58
11720 <1% 90 $123.96
86706 <1% 13 $121.39
0011A <1% 17 $88.40
80076 <1% 12 $62.70
82570 <1% 17 $51.83
85007 <1% 26 $41.96
J2270 Injection, morphine sulfate, up to 10 mg <1% 25 $41.55
85018 <1% 27 $35.43
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 13 $33.40
P9604 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge <1% 62 $22.43
11719 <1% 16 $17.99
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 67 $4.94
J7120 Ringers lactate infusion, up to 1000 cc <1% 14 $3.25
85014 <1% 12 $2.13
P9603 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled <1% 57 $1.61
J7030 Infusion, normal saline solution , 1000 cc <1% 61 $0.60
A9270 Non-covered item or service 0% 131 $0.00
95886 0% 18 $0.00
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 0% 13 $0.00
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 0% 29 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSHENEFIELD, JASON (CEO)
Same official

Other billing entities under SHENEFIELD, JASON

Full network →
ProviderLocationPaid
Phelps County Regional Medical CenterRolla, MO$3.38M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.